What Stratedigm does

Stratedigm, Inc. is a privately held biotechnology instrumentation company founded in November 2004 and headquartered in San Jose, California. The company designs, manufactures, and sells configurable benchtop flow cytometers (S1000 series, including the S1000EON and S1000EON Spectra, plus the entry-level SE520EON) and an integrated high-throughput automation suite (A600 HTAS auto-sampler, A640 CPM cell prep module, A710 HTH plate hotel, A800/A810 cell incubators, and A900 IPC intelligent centrifuge). Core technical differentiators include patent-protected Iso-Pressure Fluidics, Dynamic Seal, Opti-Symmetric Excitation Architecture, and Smart Detect technologies, all unified under the CellCapTure software platform with optional Visual Protocol Designer and Multi-Plate Conductor (ML-driven) modules. All products are developed and manufactured in Silicon Valley with field-upgradeable, backwards-compatible architecture.

The company generates revenue through direct enterprise sales of configurable flow cytometry hardware, recurring annual service contracts (including 2-year standard warranty and the Flowraissance program), software licenses and upgrades, and consumables/accessories. Go-to-market combines direct field sales to research institutions, pharmaceutical/biotech companies, and clinical immunology facilities with channel partnerships (Certified Genetool for global new/certified/refurbished distribution; LK BioScience for South Korea and broader APAC expansion). The customer base is horizontally segmented across academic core labs (Yale, Harvard, University of Oklahoma as named early adopters), pharma/biotech R&D, and clinical immunology, with annual industry conference presence (CYTO, SEFCIG) as a primary mid-funnel channel.

The strategic positioning centers on future-proof, anti-obsolescence design: instruments are field-upgradeable and supported indefinitely under continuous service contracts, distinguishing Stratedigm from competitors that discontinued roughly one-third of flow cytometers on the market between 2008 and 2020. The company holds multiple US patents with several pending, maintains a 90% customer satisfaction rate, and resolves 95% of service issues remotely in minutes via industrial IoT, supporting a differentiated, high-retention business model.

Name

Stratedigm

Legal name

Stratedigm, Inc.

Website

https://stratedigm.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Stratedigm is a privately held Silicon Valley manufacturer of configurable benchtop flow cytometers and high-throughput automation suites serving academic research labs, pharmaceutical and biotech companies, and clinical immunology facilities, with a focus on field-upgradeable, future-proof instruments.

Ownership category

akta.pro rank

Product category

Flow Cytometry Instrumentation

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

akta.pro secondary industry

Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD)

Keywords

• Flow cytometry instruments
• Benchtop flow cytometers
• High-throughput automation
• Cell analysis systems
• Spectral flow cytometry

Headquarters

HQ city

San Jose

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Flow Cytometer Hardware Sales: Stratedigm generates primary revenue from selling benchtop flow cytometers including the S1000EON, S1000EON Spectra, and SE520EON. Instruments are configurable at purchase with up to 6 lasers and 30 parameters, with field-upgradeable capabilities.
2. Automation Platform Sales: Sales of automation products including A600 HTAS (High Throughput Auto Sampler), A640 CPM (Cell Prep Module), A710 HTH (High Throughput Hotel), A800/A810 CI (Cell Incubator), and A900 IPC (Intelligent Plate Centrifuge).
3. Service Contracts: Annual service contracts covering unlimited priority support, unlimited remote sessions during business hours, software updates, firmware upgrades, minor hardware upgrades, calibration, and instrument verification. Warranty periods: 2 years for S1000EON, A600 HTAS, A710 HTH; 1 year for SE520EXi and A800 CI.
4. Software Licenses and Upgrades: CellCapTure software for acquisition and analysis, with versions like 5.0 offering advanced features including Uber Compensation and Magic Gating. Visual Protocol Designer (VPD) available as optional upgrade.
5. Consumables and Accessories: Sales of consumables and accessories for flow cytometry operations.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

Core offering

Stratedigm designs, manufactures, and sells benchtop flow cytometers (S1000EON, S1000EON Spectra, SE520EON) and an integrated automation suite (A600 HTAS, A640 CPM, A710 HTH, A800/A810 CI, A900 IPC) for research, pharmaceutical, and biotechnology laboratories. The company also provides CellCapTure acquisition/analysis software with optional Visual Protocol Designer and Multi-Plate Conductor modules, backed by service contracts, an Anti-Obsolescence Guarantee, and the Flowraissance upgrade program.

Product overview

Stratedigm offers a comprehensive flow cytometry platform centered on its S1000 series benchtop flow cytometers, including the flagship S1000EON and the entry-level SE520EON, with the upcoming S1000EON Spectra adding spectral cytometry capabilities. The platform is complemented by an extensive automation suite comprising the A600 HTAS for high-throughput sampling, A640 CPM for cell preparation with bulk reagent handling, A710 HTH for plate storage, A800/A810 cell incubators with temperature control, and the A900 IPC intelligent centrifuge. All instruments are controlled through the unified CellCapTure software platform, which offers optional modules including the patent-pending Visual Protocol Designer for drag-and-drop automation protocol creation and the Multi-Plate Conductor leveraging machine learning for optimizing multi-plate experiment scheduling. The company distinguishes itself through its Anti-Obsolescence Guarantee and Flowraissance program, ensuring instruments remain upgradeable and supported for decades.

Differentiator

Problem solved

Functional benefit

Products and services

• S1000EON Spectra Next-generation benchtop flow cytometer supporting both conventional and spectral flow cytometry modes for research and clinical labs.
• S1000EON Flagship configurable benchtop flow cytometer with up to 6 lasers and 30 parameters, TRUE 5-decade dynamic range, field-upgradeable and backwards compatible.
• SE520EON Entry-level fixed-configuration 2-laser, 6-color benchtop flow cytometer with event rate up to 20,000 events per second.
• A600 HTAS High Throughput Auto Sampler with Flat-6 technology for automated plate-based sample acquisition on Stratedigm cytometers.
• A640 CPM Cell Prep Module with Easy-Dock technology for bulk reagent handling, four 1-liter reservoirs with magnetic docking, and intelligent fluid level tracking.
• A710 HTH High Throughput Hotel for automated plate storage and management with intelligent fluidics management for long sample runs and remote system control.
• A800 CI Cell Incubator with orbital shaking, CO2, and humidity control for climate-controlled incubation within the Stratedigm automation suite.
• A810 CI Compact modular cell incubator with no motors, solenoids, or pneumatic actuators; temperature control from 8C to 40C; accommodates up to 6 plates or tube holders per unit.
• A900 IPC Intelligent Plate Centrifuge with Automatic Plate Balancing, direct drive motor, and F1-grade ceramic bearings; integrates within the Stratedigm Automation Suite or runs standalone.
• CellCapTure Software Full acquisition and analysis software for Stratedigm cytometers with templates, auto-compensation, post-color compensation, batch analysis, calculation sheets, and overlays; supports single tubes through 384-well plates.
• Visual Protocol Designer (VPD) Patent-pending drag-and-drop system (U.S. Patent No. 10338897B2) for creating complex automated protocols covering pipetting, mixing, incubation, decanting, automated compensation, and centrifugation.
• Multi-Plate Conductor (MPC) Patent-pending machine-learning software that optimizes multi-plate experiment scheduling, achieving up to 30% reduction in additional processing time per plate (up to 90% possible).
• Cryo-Blue Detector Ultra-sensitive blue detector upgrade offering up to two-fold sensitivity increase for better resolution of dim signals and more flexible multi-parameter panel designs.
• Flowraissance Program Trademarked customer care program providing complimentary upgrade to the latest Stratedigm hardware and software platform for S1000 cytometers 10+ years old under continuous service contract.
• Anti-Obsolescence Guarantee Trademarked guarantee that if a component on an instrument under uninterrupted service contract fails or is unavailable, Stratedigm upgrades the system at no charge.

Quantifiable outcome

• 95% of service issues resolved remotely in minutes using industrial IoT technology
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature10 records

Partnerships

Two partnerships are on record, tiered core and regional.

• Certified Genetool, Inc.coreChannel Partner/ Reseller/ Distributor · 9 December 2024Strategic partnership combining Stratedigm's state-of-the-art flow cytometry technology with Certified Genetool's trusted service and distribution network. Certified Genetool offers Stratedigm's full range of products including S1000, A600 HTAS, and other platforms, along with comprehensive service contracts, preventive maintenance, and Certified Genetool's signature warranties. CGI has been a trusted provider of new, certified, and refurbished lab equipment for over 18 years serving academic, biotech, and pharmaceutical industries worldwide.
• LK BioScienceregionalChannel Partner/ Reseller/ Distributor · 30 October 2012Strategic agreement for commercial distribution of Stratedigm analyzers in South Korea. LK BioScience has been distributing flow cytometry reagents, instrumentation, and biomedical products since 2005. Executives Yu-sik Lim and Barbie Kim bring over 35 years of combined experience in sales and marketing of flow cytometry products for companies such as BD Korea. Partnership also intended to expand to Singapore, China, and Thailand.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Beckman Coulter Life Sciences: Direct competitor in benchtop flow cytometry with the CytoFLEX and CytoFLEX S lines. Beckman Coulter shares Stratedigm's emphasis on compact, sensitive benchtop analyzers for research and core-lab customers, and is one of the principal players against which Stratedigm's S1000EON competes on footprint, sensitivity, and configurability.
• Cytek Biosciences: Pioneer and market leader in spectral flow cytometry with the Northern Lights and Aurora systems. Now that Stratedigm has launched the S1000EON Spectra, the two companies are directly comparable on spectral capability, with Cytek holding a substantial first-mover and installed-base advantage.
• BD Biosciences: Long-established flow cytometry leader with the FACSDiscover, FACSymphony, and BD CellView product families. BD competes with Stratedigm across research and clinical segments, with substantially greater R&D, sales, and service scale, and serves many of the same academic and pharma customers.
• Sony Biotechnology: Competitor in spectral and conventional flow cytometry with the CGX10 and ID7000 platforms. Sony Biotechnology targets similar core-lab and immunology workflows as Stratedigm and is one of the closest comparables on spectral flow cytometry capability and benchtop form factor.
• Agilent Technologies: Competitor in benchtop flow cytometry via the NovoCyte, NovoCyte Quanteon, and NovoSampler Pro product lines. Agilent targets similar academic and pharma research customers as Stratedigm, with a focus on compact, configurable benchtop analyzers and walk-away automation.
• Bio-Rad Laboratories: Competitor in flow cytometry with the ZE5 Cell Analyzer and S3e Cell Sorter. Bio-Rad serves similar research, cell biology, and immunology customers and overlaps with Stratedigm in the benchtop live-cell analysis segment.

Broad incumbents

• Thermo Fisher Scientific: Broad life sciences instrumentation incumbent that sells the Attune NxT flow cytometer, Invitrogen flow cytometry reagents, and a much wider portfolio. As the largest life-science tools player, Thermo Fisher competes with Stratedigm across reagent bundling, pricing, and integrated workflow offerings.
• Danaher Corporation: Parent of Beckman Coulter Life Sciences, Leica Microsystems, and other life sciences tools brands. As a multi-billion-dollar life sciences platform, Danaher's flow cytometry subsidiaries compete with Stratedigm on portfolio breadth, clinical/IVD reach, and CAPEX cycles of large pharma customers.

Emerging players

• Standard BioTools (formerly Fluidigm): Player in high-parameter cytometry with the CyTOF mass cytometry and Imaging Mass Cytometry platforms. Targets a partially overlapping customer base (immunology, pharma biomarker discovery) but uses a fundamentally different (mass-based) detection technology.

Others

• Cytobank (now part of Beckman Coulter): Cloud-based flow cytometry data analysis platform, now part of Beckman Coulter. Provides complementary software to Stratedigm's CellCapTure and VPD offerings, and is increasingly bundled into the competitive landscape for high-dimensional cytometry data analysis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/stratedigminc
• YouTubeyoutube.com/user/stratedigminc
• Facebookfacebook.com/StratedigmInc
• LinkedInlinkedin.com/company/stratedigm-inc.
• Instagraminstagram.com/stratedigminc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stratedigm